REGISTERED
on 28 Dec 2021
Last Applicant/ Owned by
Oxford Science Park, Robert Robinson Ave
Oxford
GB
OX44GA
Serial Number
90072104 filed on 24th Jul 2020
Registration Number
6600090 registered on 28th Dec 2021
Filing Basis
No Filing Basis
Disclaimer
NO DATA
ARGONAUT
Epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; epigenetic drugs targeting arginine methylation in cancer; pharmaceutical preparations in the nature of inhibitors of arginine methylation for the treatment of cancer; pharmaceutical preparations in the nature of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment v Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research and development services in the pharmaceutical and biotechnology fields; medical research and development services in the pharmaceutical and biotechnology fields; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccines, therapeutic vaccines for treating cancer and cancer therapy subsection vaccines; research and development in the field of compounds for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer; consultancy, advisory and information services relating to and connected with the aforementioned services
Class [005]
Pharmaceutical Products
Epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; epigenetic drugs targeting arginine methylation in cancer; pharmaceutical preparations in the nature of inhibitors of arginine methylation for the treatment of cancer; pharmaceutical preparations in the nature of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; pharmaceutical compounds for the treatment, diagnosis, detection and prevention of cancer; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and prevention of cancer; biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer
Mark Details
Serial Number
No 90072104
Mark Type
No Service Mark
Attorney Docket Number
No 033531-00001
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 28th Dec 2021 | REGISTERED-PRINCIPAL REGISTER |
| 12th Oct 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 12th Oct 2021 | PUBLISHED FOR OPPOSITION |
| 22nd Sep 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 03rd Sep 2021 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 03rd Sep 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 03rd Sep 2021 | EXAMINER'S AMENDMENT ENTERED |
| 03rd Sep 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 03rd Sep 2021 | EXAMINERS AMENDMENT E-MAILED |
| 03rd Sep 2021 | EXAMINERS AMENDMENT -WRITTEN |